163 related articles for article (PubMed ID: 35837183)
1. Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
J Gastrointest Oncol; 2022 Jun; 13(3):1402-1412. PubMed ID: 35837183
[TBL] [Abstract][Full Text] [Related]
2. Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial.
Zhu X; Liu W; Cao Y; Ju X; Zhao X; Jiang L; Ye Y; Zhang H
EClinicalMedicine; 2023 Jan; 55():101764. PubMed ID: 36471691
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):386-394. PubMed ID: 34974972
[TBL] [Abstract][Full Text] [Related]
5. High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in patients with borderline resectable and locally advanced pancreatic cancer.
Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
J Gastrointest Oncol; 2022 Feb; 13(1):368-379. PubMed ID: 35284125
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation.
Sutera P; Bernard ME; Wang H; Bahary N; Burton S; Zeh H; Heron DE
Front Oncol; 2018; 8():52. PubMed ID: 29564223
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.
Ryan JF; Groot VP; Rosati LM; Hacker-Prietz A; Narang AK; McNutt TR; Jackson JF; Le DT; Jaffee EM; Zheng L; Laheru DA; He J; Pawlik TM; Weiss MJ; Wolfgang CL; Herman JM
Ann Surg Oncol; 2018 Jan; 25(1):280-289. PubMed ID: 29063299
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Factors for Elderly Patients Treated With Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma.
Sutera PA; Bernard ME; Wang H; Heron DE
Front Oncol; 2018; 8():282. PubMed ID: 30101127
[No Abstract] [Full Text] [Related]
9. Patterns of Failure Following Preoperative Chemotherapy and Stereotactic Body Radiation Therapy and Resection for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer.
Libbey N; Gallagher L; Cantalino J; Weinberg BA; Noel MS; He AR; Radkani P; Marshall JL; Weiner LM; Jackson PG; Fishbein TM; Winslow ER; Haddad N; Rashid A; Unger KR
J Gastrointest Cancer; 2024 Jun; 55(2):852-861. PubMed ID: 38347342
[TBL] [Abstract][Full Text] [Related]
10. Salvage Ablative Radiotherapy for Isolated Local Recurrence of Pancreatic Adenocarcinoma following Definitive Surgery.
Dee EC; Ng VC; O'Reilly EM; Wei AC; Lobaugh SM; Varghese AM; Zinovoy M; Romesser PB; Wu AJ; Hajj C; Cuaron JJ; Khalil DN; Park W; Yu KH; Zhang Z; Drebin JA; Jarnagin WR; Crane CH; Reyngold M
J Clin Med; 2024 Apr; 13(9):. PubMed ID: 38731159
[No Abstract] [Full Text] [Related]
11. Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.
Aghdam N; Lischalk JW; Marin MP; Hall C; O'Connor T; Campbell L; Suy S; Collins SP; Margolis M; Krochmal R; Anderson E; Collins BT
Front Oncol; 2021; 11():728519. PubMed ID: 34912703
[TBL] [Abstract][Full Text] [Related]
12. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.
Koong AJ; Toesca DAS; von Eyben R; Pollom EL; Chang DT
Adv Radiat Oncol; 2017; 2(1):27-36. PubMed ID: 28740913
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic body radiation therapy for palliative management of pancreatic adenocarcinoma in elderly and medically inoperable patients.
Ryan JF; Rosati LM; Groot VP; Le DT; Zheng L; Laheru DA; Shin EJ; Jackson J; Moore J; Narang AK; Herman JM
Oncotarget; 2018 Mar; 9(23):16427-16436. PubMed ID: 29662656
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic Body Radiation Therapy for Salvage Treatment of Recurrent Non-Small Cell Lung Cancer.
Kowalchuk RO; Waters MR; Richardson KM; Spencer KM; Larner JM; Kersh CR
Pract Radiat Oncol; 2020; 10(6):e475-e484. PubMed ID: 32454175
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic body radiation therapy for locally advanced pancreatic cancer.
Jung J; Yoon SM; Park JH; Seo DW; Lee SS; Kim MH; Lee SK; Park DH; Song TJ; Ryoo BY; Chang HM; Kim KP; Yoo C; Jeong JH; Kim SC; Hwang DW; Lee JH; Song KB; Jo YY; Park J; Kim JH
PLoS One; 2019; 14(4):e0214970. PubMed ID: 30978229
[TBL] [Abstract][Full Text] [Related]
16. Upfront Chemotherapy Followed by Stereotactic Body Radiation Therapy with or without Surgery in Older Patients with Localized Pancreatic Cancer: A Single Institution Experience and Review of the Literature.
Reddy AV; Sehgal S; Hill CS; Zheng L; He J; Herman JM; Meyer J; Narang AK
Curr Oncol; 2022 Jan; 29(1):308-320. PubMed ID: 35049702
[TBL] [Abstract][Full Text] [Related]
17. Oligo metastatic renal cell carcinoma: stereotactic body radiation therapy, if, when and how?
Marvaso G; Corrao G; Oneta O; Pepa M; Zaffaroni M; Corso F; Gandini S; Cecconi A; Zerini D; Mazzola GC; Augugliaro M; Cossu Rocca M; Verri E; Cattani F; La Fauci F; Bergamaschi L; Luzzago S; Mistretta AF; Musi G; Nolè F; De Cobelli O; Orecchia R; Jereczek-Fossa BA
Clin Transl Oncol; 2021 Aug; 23(8):1717-1726. PubMed ID: 33687659
[TBL] [Abstract][Full Text] [Related]
18. Patterns of Failure in Patients With Borderline Resectable/Locally Advanced Pancreatic Cancer After Preoperative Chemotherapy and Stereotactic Body Radiation Therapy.
Chung EM; Lu DJ; Nguyen AT; Hendifar AE; Nissen NN; Gong J; Osipov A; Gangi A; Attiyeh MA; Atkins KM; Kamrava M
Adv Radiat Oncol; 2024 May; 9(5):101471. PubMed ID: 38550374
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.
Hill CS; Rosati LM; Hu C; Fu W; Sehgal S; Hacker-Prietz A; Wolfgang CL; Weiss MJ; Burkhart RA; Hruban RH; De Jesus-Acosta A; Le DT; Zheng L; Laheru DA; He J; Narang AK; Herman JM
Ann Surg Oncol; 2022 Apr; 29(4):2456-2468. PubMed ID: 35129721
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of Stereotactic Body Radiation Therapy for Locoregional Recurrences After Prior Chemoradiation for Advanced Esophageal Carcinoma.
Seyedin SN; Gannon MK; Plichta KA; Abushahin L; Berg DJ; Arshava EV; Parekh KR; Keech JC; Caster JM; Welsh JW; Allen BG
Front Oncol; 2020; 10():1311. PubMed ID: 32850412
[No Abstract] [Full Text] [Related]
[Next] [New Search]
